Malignant Ovarian Serous Tumor — Trials

Malignant Ovarian Serous Tumor — Trials · CancerIndex

Clinical trials

Registered studies

154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 69
Recruiting: 29
Ph III recruiting: 4
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 51–65 of 65 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04716686	Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma	recruiting	Phase 2	83	Shandong UniversityOTHER	1	Jan 5, 2024	clinicaltrials
NCT05961124	Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer	recruiting	Phase 2	40	Sunnybrook Health Sciences CentreOTHER	1	Nov 22, 2023	clinicaltrials